← Back
Data updated: Mar 10, 2026
ALEMBIC PHARMS LTD
CardiovascularNeurologyRespiratory
ALEMBIC PHARMS LTD is a generic drug manufacturer focused on Cardiovascular, Neurology, Respiratory. Key products include FLUOXETINE HYDROCHLORIDE.
2009
Since
21
Drugs
-
Trials
236
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 2026-02-17
Labeling
METRONIDAZOLE 2026-02-17
Labeling
METRONIDAZOLE 2026-02-17
Labeling
METRONIDAZOLE 2026-02-13
VENLAFAXINE HYDROCHLORIDE 2026-01-30
Labeling
LAMOTRIGINE 2026-01-30
Labeling
LAMOTRIGINE 2026-01-30
Labeling
LAMOTRIGINE 2026-01-30
Labeling
LAMOTRIGINE 2026-01-30
Labeling
LAMOTRIGINE 2026-01-30
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 57%
4 drugs
Neurology 14%
1 drugs
Respiratory 14%
1 drugs
Gastroenterology 14%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
GE HEALTHCARE specialty
Neurology, Cardiovascular, Respiratory
APOTHECON specialty
Cardiovascular, Gastroenterology, Respiratory
LEDERLE big-pharma
Cardiovascular, Neurology, Respiratory
Novartis big-pharma
Cardiovascular, Respiratory
VALIDUS PHARMS specialty
Cardiovascular, Gastroenterology, Neurology
Active (10)
Discontinued (8)
Company Info
- First Approval
- 2009-02-18
- Latest
- 2025-12-16
- Applications
- 33